Cyclodextrins in the antiviral therapy
This review discusses the basic properties of the different cyclodextrin derivatives, their potential in antiviral formulations, and the prevention and
Tag: Covid-19
Nitric oxide and COVID-19
A clinical trial in United Kingdom confirms SaNOtize’s breakthrough treatment for COVID-19 SaNOtize R. & D. Corp, a Canadian Biotech
Combinatory treatment of Covid-19 with remdesivir and the repurposed drugs fluoxetine and itraconazole
The antiviral potential of the antifungal itraconazole and the antidepressant fluoxetine was tested on the production of infectious SARS-CoV-2 particles
A combinatory treatment of Hepatitis C drugs with Remdesivir show strong effectiveness against COVID-19
Science News reported that a combination of remdesivir, a drug formulated by SBECD and currently approved in the United States
Peripheral infiltration of remdesivir in 3 patients with COVID-19: Case series and discussion
The scientists from Netherland reported 3 cases on remdesivir infiltration in patients with Covid-19. In the first case, a 91-year-old
The talks of webinar “Meet the Experts: Applications of Cyclodextrins in the Pharma Industries” on youtube
The webinar held on Apr. 15-16, 2021 and organized by Cyclolab received wide attantion. It was in the afternoon Central
Inhaled budesonide in the treatment of early COVID-19
The Lancet published on an open-label, parallel-group, phase 2, randomised controlled trial, on inhaled budesonide (Ramakrishnan et al. 2021). Participants
Targeting Lipid Rafts as a Strategy Against Coronavirus
Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol. These regions are characterized by highly ordered and
Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: characterization of electrospun- and lyophilized formulations
Veklury™ by Gilead Sciences, Inc., containing antiviral drug, remdesivir (REM) has received emergency authorization in the USA and in Europe
Reduced mortality rate and shorter time for clinical improvement upon Remdesivir treatment
This retrospective comparative effectiveness research study was conducted from March 4 to August 29, 2020, in a 5-hospital health system